Gene expression of transforming growth factor β receptors I and II in non-small-cell lung tumors

Cytokine

Volumn 24, Issue 5, 2003, Pages 182-189

  Colasante, Antonella ^a,b   Aiello, Francesca B ^a,c   Brunetti, Mauro ^a,c   Di Giovine, Francesco S ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Non small cell lung tumors; TGF ; TGF receptors

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CANCER MORTALITY; CANCER STAGING; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; THORACOTOMY; TUMOR CELL; TUMOR GROWTH;

EID: 0142164888     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.08.008     Document Type: Article

References (36)

1. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
2. Mc Cartney-Francis N.L., Wahl S.M. Transforming growth factor beta: a matter of life and death. J Leukoc Biol. 55:1994;401-409.
3. Colasante A., Mascetra N., Brunetti M., Lattanzio G., Diodoro M.G., Caltagirone S., et al. Transforming growth factor beta 1, interleukin-8 and interleukin-1 in non-small-cell lung tumors. Am J Respir Crit Care Med. 156:1997;968-973.
4. Takanami I., Tanaka F., Hashizume T., Kikuchi K., Yamamoto Y., Yamamoto T., et al. Transforming growth factor-beta isoforms expressions in pulmonary adenocarcinomas as prognostic markers: an immunohistological study of one hundred and twenty patients. Oncology. 54:1997;122-128.
5. Takanami I., Tanaka F., Hashizume T., Kodaira S. Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study. J Surg Oncol. 64:1997;262-267.
6. Hasegawa Y., Takanashi S., Kanehira Y., Tsushima T., Imai T., Okumura K. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with non small cell lung carcinoma. Cancer. 91:2001;964-971.
7. Kong F.M., Washington M.K., Jirtle R.L., Anscher M.S. Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer. 16:1996;47-59.
8. Jetten A.M., Shirley J.E., Stoner G. Regulation of proliferation and differentiation of respiratory tract epithelial cells by TGF beta. Exp Cell Res. 167:1986;539-549.
9. Jakowlew S.B., Mathias A., Chung P., Moody T.W. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines. Cell Growth Differ. 6:1995;465-476.
10. Kim W.S., Park C., Jung Y.S., Kim H.S., Han J., Park C.H., et al. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res. 19:1999;301-306.
11. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L.Z., Lutterbaugh J., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
12. Garrigue-Antar L., Munoz-Antonia T., Antonia S.J., Gesmonde J., Vellucci V.F., Reiss M. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55:1995;3982-3987.
13. Brattain M.G., Markowitz S.D., Willson J.K.V. The type II transforming growth factor-beta receptor as a tumor-suppressor gene. Curr Opin Oncol. 8:1996;49-53.
14. Derynck R., Akhurst R.J., Balmain A. TGF-β signalling in tumor suppression and cancer progression. Nat Genet. 29:2001;117-129.
15. Kim I.Y., Ahn H.J., Lang S., Oefelein M.G., Oyasu R., Kozlowski J.M., et al. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res. 4:1998;1625-1630.
16. Knaus P.I., Lindemann D., DeCoteau J.F., Perlman R., Yankelev H., Hille M., et al. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol. 16:1996;3480-3489.
17. Tokunaga H., Lee D.H., Kim I.Y., Wheeler T.M., Lerner S.P. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin Cancer Res. 5:1999;2520-2525.
18. Kang Y., Prentice M.A., Mariano J.M., Davarya S., Linnoila R.I., Moody T.W., et al. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp Lung Res. 26:2000;685-707.
19. Kohlberger P.D., Obermair A., Sliutz G., Heinzl H., Koelbl H., Breitenecker G., et al. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol. 105:1996;705-710.
20. Grandis J.R., Melhem M.F., Barnes E.L., Tweardy D.J. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 78:1996;1284-1292.
21. Francis S.E., Duff G.W. 7B6, a ubiquitous mRNA with significant homology to L41 human ribosomal protein RNA. Nucleic Acids Res. 21:1993;2944.
22. Kaczmarek L., Calabretta B., Baserga R. Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes. Proc Natl Acad Sci U S A. 82:1985;5375-5379.
23. Chen T., Triplett J., Dehner B., Hurst B., Colligan B., Pemberton J., et al. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res. 61:2001;4679-4682.
24. Periyasamy S., Sun L., Gentry L.E., Brattain M.G. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. J Cell Physiol. 168:1996;711-720.
25. Wells R.G., Yankelev H., Lin H.Y., Lodish H.F. Biosynthesis of the type I and type II TGF-beta receptors. Implications for complex formation. J Biol Chem. 272:1997;11444-11451.
26. Koli K.M., Arteaga C.L. Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation. J Biol Chem. 272:1997;6423-6427.
27. Park K., Kim S.J., Bang Y.J., Park J.G., Kim N.K., Roberts A.B., et al. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci U S A. 91:1994;8772-8776.
28. Ogasa H., Noma T., Murata H., Kawai S., Nakazawa A. Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: heterogeneity of the mRNA. Gene. 181:1996;185-190.
29. Vaillancourt C., Petit A., Belisle S. Expression of human placental D2-dopamine receptor during normal and abnormal pregnancies. Placenta. 19:1998;73-80.
30. Brotherick I., Robson C.N., Browell D.A., Shenfine J., White M.D., Cunliffe W.J., et al. Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression. Cytometry. 32:1998;301-308.
31. Roy S.K., Kole A.R. Transforming growth factor-beta receptor type II expression in the hamster ovary: cellular site(s), biochemical properties, and hormonal regulation. Endocrinology. 136:1995;4610-4620.
32. Koli K.M., Arteaga C.L. Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells. Cancer Res. 57:1997;970-977.
33. Capocasale R.J., Lamb R.J., Vonderheid E.C., Fox F.E., Rook A.H., Nowell P.C., et al. Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sezary patients. Proc Natl Acad Sci U S A. 92:1995;5501-5505.
34. Anderson M., Muro-Cacho C., Cordero J., Livingstone S., Munoz-Antonia T. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 125:1999;849-854.
35. Rottman J.B., Freeman E.B., Tonkonogy S., Tompkins M.B. A reverse transcription-polymerase chain reaction technique to detect feline cytokine genes. Vet Immunol Immunopathol. 45:1995;1-18.
36. Reisdorf P., Lawrence D.A., Sivan V., Klising E., Martin M.T. Alteration of transforming growth factor-β1 response involves down-regulation of smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol. 159:2001;263-272.